EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Ependymoma‐like tumor with mesenchymal differentiation ( ELTMD ) with ZFTA:NCOA1 fusion: A diagnostic challenge

Pranav Dorwal iD, Christine White iD, Anna Fn Goh, Amit Kumar, Jane McEniery, Rick Walker, Thomas Robertson

Neuropathology · 2024

DOI: 10.1111/neup.12952 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology, 2024. Verfasst von Pranav Dorwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Genomics, Monash Health, Clayton, Australia. Hauptthemen laut MEDLINE: Ependymoma, Nuclear Receptor Coactivator 1. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Australia, Carrie's Beanies 4 Brain Cancer Foundation, Robert Connor Dawes Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ependymal tumors are classified based on their location, histology, and molecular characteristics. Supratentorial ependymomas (ST‐EPNs) are a group of circumscribed supratentorial gliomas, which usually have pathogenic fusions involving either zinc finger translocation associated (ZFTA) (formerly C11orf95) or YAP1 . A subtype of ependymoma was recently described and labeled ependymoma‐like tumors with mesenchymal differentiation (ELTMDs). We describe a case of a 5‐year‐old boy who presented with a right frontal tumor. The diagnosis was challenging, and a correct diagnosis could only be reached after reanalysis of methylation data with a more recent version of the classifier and RNA fusion testing, which revealed ZFTA:NCOA1 (nuclear receptor coactivator 1) fusion. There are only a handful of cases of this entity, which is being reported for its rarity and the diagnostic challenge it poses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpendymomaNuclear Receptor Coactivator 1HumansMaleChild, PreschoolSupratentorial NeoplasmsOncogene Proteins, FusionBrain NeoplasmsProteinsTranscription Factors

Stichwörter der Autor:innen

EpendymomaFusionMesenchymalMethylationRNA

Substanzen

Nuclear Receptor Coactivator 1Oncogene Proteins, FusionProteinsNCOA1 protein, humanZFTA protein, humanTranscription Factors

Autor:innen und Institutionen

  • Diagnostic Genomics, Monash Health, Clayton, Australia.
  • Anatomical Pathology, Monash Health, Clayton, Australia.
  • School of Clinical Sciences, Monash University, Clayton, Australia.
  • Victorian Clinical Genetics Services, Parkville, Australia.
  • Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Australia.
  • Molecular and Translational Science, Monash University, Clayton, Australia.

ORCID-Profile: Pranav Dorwal, Christine White

Förderung

  • Cancer Australia
  • Carrie's Beanies 4 Brain Cancer Foundation
  • Robert Connor Dawes Foundation
  • Victorian Government's Operational Infrastructure Support Program

Zitieren

APA

Dorwal, P., White, C., Goh, A. F., Kumar, A., McEniery, J., Walker, R., & Robertson, T. (2024). Ependymoma‐like tumor with mesenchymal differentiation ( ELTMD ) with ZFTA:NCOA1 fusion: A diagnostic challenge. Neuropathology. https://doi.org/10.1111/neup.12952

Vancouver

Dorwal P, White C, Goh AF, Kumar A, McEniery J, Walker R, et al. Ependymoma‐like tumor with mesenchymal differentiation ( ELTMD ) with ZFTA:NCOA1 fusion: A diagnostic challenge. Neuropathology. 2024. doi:10.1111/neup.12952

BibTeX
@article{Dorwal2024,
  author = {Dorwal, Pranav and White, Christine and Goh, Anna Fn and Kumar, Amit and McEniery, Jane and Walker, Rick and Robertson, Thomas},
  title = {Ependymoma‐like tumor with mesenchymal differentiation ( ELTMD ) with ZFTA:NCOA1 fusion: A diagnostic challenge},
  journal = {Neuropathology},
  year = {2024},
  doi = {10.1111/neup.12952}
}
Kostenlos starten →